Essity (ESSITY B) Aandelenoverzicht
Essity AB (publ) ontwikkelt, produceert en verkoopt hygiëne- en gezondheidsproducten en -diensten in Europa, Noord- en Latijns-Amerika en Azië. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 3/6 |
Beloningen
Risicoanalyse
ESSITY B onze risicocontroles hebben doorstaan.
ESSITY B Community Fair Values
Create NarrativeSee what 35 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Essity AB (publ) Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | SEK 261.60 |
| 52 Week Hoogtepunt | SEK 293.10 |
| 52 Week Laag | SEK 236.10 |
| Bèta | 0.37 |
| 1 maand verandering | -3.54% |
| 3 maanden verandering | -2.21% |
| 1 Jaar Verandering | 7.61% |
| 3 jaar verandering | 12.37% |
| 5 jaar verandering | -3.04% |
| Verandering sinds IPO | 5.27% |
Recent nieuws en updates
Narratiefupdate • Sep 17
ESSITY B: Cost Control And Margin Discipline Will Support Future Upside Potential
Essity's analyst price target has shifted from SEK 310 to SEK 320, as analysts factor in adjusted revenue growth, profit margin and future P/E assumptions, alongside mixed Street views that range from SEK 235 on the downside to SEK 320 on the upside. Analyst Commentary Analyst opinions on Essity are split, with recent research highlighting both upside and downside scenarios for the stock.
Narratiefupdate • Sep 03
ESSITY B: New Cost Inflation Cycle Will Continue To Pressure Margins
Essity's analyst price target has been reset lower from about SEK 219 to SEK 215, as analysts factor in fresh Sell ratings, lower SEK-based targets, concerns about a new cost inflation cycle, and potential downside risk to consensus estimates. Analyst Commentary Recent Street research on Essity shows a clear split in views, with some investors seeing long term upside potential and others focusing on emerging risks.Narratiefupdate • Aug 12
ESSITY B: Business Review And Capital Returns Will Support Future Upside Potential
Essity's updated analyst price target has shifted to SEK 310 from SEK 300 as analysts factor in a slightly higher discount rate, a different balance of revenue growth and profit margin expectations, and recent Street research highlighting potential downside risk to consensus estimates due to pricing lagging input cost inflation. What’s in the News for Essity Essity has opened a new recycled fiber facility in the UK that expands capacity and strengthens domestic fiber supply for hygiene paper products, supporting more circular production.
Narratiefupdate • Jul 29
ESSITY B: Cost Pressures And Tissue Review Will Shape Future Returns
Essity's analyst price target has shifted from SEK 265.07 to SEK 271.60. Analysts point to updated fair value estimates and revised assumptions around revenue growth, profit margins and future P/E as key drivers behind the change.Recent updates
Narratiefupdate • Sep 17
ESSITY B: Cost Control And Margin Discipline Will Support Future Upside Potential
Essity's analyst price target has shifted from SEK 310 to SEK 320, as analysts factor in adjusted revenue growth, profit margin and future P/E assumptions, alongside mixed Street views that range from SEK 235 on the downside to SEK 320 on the upside. Analyst Commentary Analyst opinions on Essity are split, with recent research highlighting both upside and downside scenarios for the stock.Narratiefupdate • Sep 03
ESSITY B: New Cost Inflation Cycle Will Continue To Pressure Margins
Essity's analyst price target has been reset lower from about SEK 219 to SEK 215, as analysts factor in fresh Sell ratings, lower SEK-based targets, concerns about a new cost inflation cycle, and potential downside risk to consensus estimates. Analyst Commentary Recent Street research on Essity shows a clear split in views, with some investors seeing long term upside potential and others focusing on emerging risks.Narratiefupdate • Aug 12
ESSITY B: Business Review And Capital Returns Will Support Future Upside Potential
Essity's updated analyst price target has shifted to SEK 310 from SEK 300 as analysts factor in a slightly higher discount rate, a different balance of revenue growth and profit margin expectations, and recent Street research highlighting potential downside risk to consensus estimates due to pricing lagging input cost inflation. What’s in the News for Essity Essity has opened a new recycled fiber facility in the UK that expands capacity and strengthens domestic fiber supply for hygiene paper products, supporting more circular production.Narratiefupdate • Jul 29
ESSITY B: Cost Pressures And Tissue Review Will Shape Future Returns
Essity's analyst price target has shifted from SEK 265.07 to SEK 271.60. Analysts point to updated fair value estimates and revised assumptions around revenue growth, profit margins and future P/E as key drivers behind the change.Narratiefupdate • Jul 15
ESSITY B: Ongoing Pricing And Margin Concerns Will Continue To Pressure Sentiment
The analyst price target for Essity has edged higher from SEK 215 to about SEK 219, with analysts pointing to updated assumptions on fair value, revenue growth and profit margins, even as they weigh recent Street research such as the JPMorgan downgrade. What’s in the News for Essity Essity plans to commence share repurchases on May 12, 2026, under an authorization from the March 26, 2026 Annual General Meeting, with scope to buy back shares so that the company does not hold more than 10% of its issued share capital.Narratiefupdate • Jul 01
ESSITY B: Capital Returns And Business Review Will Shape Measured Future Upside
Essity's analyst price target has been revised from SEK 320 to SEK 300, as analysts factor in a slightly higher discount rate, updated assumptions on revenue growth and margins, and recent rating and target changes from JPMorgan and UBS. Analyst Commentary Recent research on Essity highlights a mix of caution and optimism, with the reduced SEK 300 price target sitting alongside differing views on how the company can execute on its plans.Narratiefupdate • Jun 17
ESSITY B: Cautious Rating Shifts And Tissue Review Will Shape Outlook
Analysts have lowered their price targets on Essity, with the consensus reduced by SEK 40 as they incorporate recent rating changes and updated assumptions from the latest research reports. Analyst Commentary Recent updates on Essity show analysts refining their views on the stock, with several price target cuts and a downgrade from JPMorgan shaping a more cautious tone around valuation and execution.Narratiefupdate • Jun 03
ESSITY B: Neutral View As Discount Rates Rise And Tissue Review Progresses
Essity’s updated analyst price target has been trimmed by about SEK 1 to around SEK 265, as analysts factor in slightly higher discount rates alongside only modest adjustments to revenue growth, profit margin and future P/E assumptions, following a series of recent target cuts and a downgrade across the Street. Analyst Commentary Recent research updates cluster around a more cautious stance, with several firms trimming price targets and JPMorgan moving to a downgrade.Narratiefupdate • May 20
ESSITY B: Ongoing Pricing Roll Off Will Continue To Pressure Sentiment
Essity's analyst price targets have been trimmed again, with recent SEK cuts from multiple banks leaving the updated fair value at SEK 215.00. Analysts are factoring in ongoing pricing roll off and limited signs of stabilization in weaker categories.Narratiefupdate • May 05
ESSITY B: Pricing Roll Off And JPMorgan Downgrade Will Pressure Sentiment
Essity's analyst fair value estimate has shifted from SEK 220.0 to SEK 215.0 as analysts factor in a slightly higher discount rate, updated views on revenue growth and margins, and a series of recent SEK price target cuts from major banks. Analyst Commentary Recent Street research on Essity has tilted more cautious, with several bearish analysts cutting SEK price targets and, in one case, JPMorgan moving to a more negative stance on the stock.Narratiefupdate • Apr 21
ESSITY B: Neutral Stance As Pricing Roll Off And Categories Remain Mixed
Essity's analyst price target has been trimmed from about SEK 278 to SEK 266, as analysts factor in updated estimates, pricing roll off, and limited signs of stabilisation in weaker categories. Analyst Commentary Recent Street research on Essity has tilted cautious, with a series of price target cuts and at least one downgrade, as analysts refresh models following the FY25 results and updated outlook for 2026.Narratiefupdate • Apr 06
ESSITY B: Pricing Roll Off Into 2026 Will Keep Sentiment Cautious
Essity's analyst fair value has been trimmed from SEK 235.0 to SEK 220.0 as analysts factor in recent price target cuts, as well as ongoing concerns around pricing roll off and weaker categories showing limited signs of stabilizing. Analyst Commentary Recent Street research around Essity has leaned cautious, with several bearish analysts trimming price targets and revisiting their assumptions after the latest FY25 results.Narratiefupdate • Mar 22
ESSITY B: Pricing Roll Off And Weaker Categories Will Keep Sentiment Cautious
Essity's analyst price target has been trimmed by around SEK 15 to SEK 252, as analysts factor in updated FY25 results, ongoing pricing roll off into 2026, and limited signs of stabilization in some weaker categories. Analyst Commentary Recent Street research has tilted more cautious on Essity, with several bearish analysts trimming price targets and rethinking their stance on the shares.Narratiefupdate • Mar 08
ESSITY B: Neutral View Balances Pricing Pressure With Firmer Margin Expectations
Narrative update on Essity Essity's analyst price target has edged down by SEK 4.71, with analysts citing slightly higher discount rates, softer revenue growth assumptions, and lower future P/E expectations, partly offset by firmer margin assumptions and recent Street research pointing to pricing pressure and weaker categories that show limited signs of stabilizing. Analyst Commentary Recent Street research on Essity has turned more cautious, with several houses trimming price targets or downgrading their stance.Narratiefupdate • Feb 22
ESSITY B: Capital Returns And Sector Rebound Potential Will Drive Future Upside
Analysts have trimmed their Essity fair value estimate to SEK 320 from SEK 325, reflecting recent downgrades and a view that sector valuations may stay cheap despite only modest adjustments to growth, margin and P/E assumptions. Analyst Commentary Recent Street research has tilted more cautious on Essity, with fair value estimates and price targets pointing to a muted near term setup for the shares.Narratiefupdate • Feb 08
ESSITY B: Cautious Rating Shifts Will Keep Multiples Compressed
Analysts have nudged their fair value estimate for Essity up from SEK 230 to SEK 235. This reflects updated views on its model and mixed recent research that includes both price target increases and downgrades to more cautious ratings.Narratiefupdate • Jan 24
ESSITY B: Dividend And Buybacks Will Support Future Upside Potential
Analysts have kept their fair value estimate for Essity steady at SEK 325, with updated models that balance a higher assumed revenue growth rate against slightly lower profit margin expectations, as well as a modestly higher future P/E informed by recent Street price targets between SEK 267 and SEK 290 and a shift to more neutral ratings. Analyst Commentary Street research around Essity has become more balanced, but there are still clear pockets of optimism that matter if you are trying to gauge how supportive the external view is around the current fair value estimate of SEK 325.Narratiefupdate • Jan 10
ESSITY B: Neutral Stance Will Meet Cost Savings And Decentralization Plan
Essity’s analyst fair value estimate has edged up from SEK 281.08 to SEK 282.29, reflecting modest model updates and mixed Street views as some analysts trim ratings and set price targets in the SEK 267 to SEK 290 range, while still seeing the shares as reasonably valued within staples. Analyst Commentary Recent research updates on Essity point to a mixed but generally balanced stance, with modest tweaks to models and price targets rather than big swings in conviction.Narratiefupdate • Dec 26
ESSITY B: Margin Discipline And Cost Savings Will Drive Future Upside Potential
Analysts have made only modest adjustments to their SEK price targets for Essity, with a small net decrease as updated post Q3 models reflect slightly softer long term revenue growth and margins, partially offset by expectations for a marginally higher future P/E multiple. Analyst Commentary Bullish analysts continue to view Essity's Q3 delivery as broadly supportive of the equity story, with updated models signaling confidence in the company’s ability to defend margins and gradually reaccelerate growth.Narratiefupdate • Dec 12
ESSITY B: Margin And Cost Savings Progress Will Support Upside Potential
Analysts have trimmed their fair value estimate for Essity to SEK 325 from SEK 330, reflecting a slightly higher assumed discount rate, even as they factor in marginally stronger long term revenue growth, improved profit margins, and a modestly lower future P E multiple following recent Street target revisions. Analyst Commentary Recent Street research reflects a more constructive stance on Essity's medium term prospects, with bullish analysts incrementally lifting price targets and refining their models following the Q3 report.Narratiefupdate • Oct 22
Analysts Cite Trough Valuation and Limited Catalysts as Essity Price Targets Edge Lower
Analysts have slightly decreased their price target for Essity, lowering it by approximately SEK 1. This adjustment reflects a continued cautious outlook as recent research points to limited immediate catalysts for the shares.Narratiefupdate • Oct 08
Demand In Feminine Care And Incontinence Will Expand Internationally
Analysts have lowered their fair value target for Essity from SEK 285.25 to SEK 282.33. They cite concerns about structural pressures and a lack of near-term catalysts, even though there are some positive longer-term trends in higher margin segments.Narratiefupdate • Sep 24
Demand In Feminine Care And Incontinence Will Expand Internationally
Essity's consensus price target was revised slightly lower to SEK285.25 amid sector-wide pressures, a shift toward higher-margin segments lacking near-term catalysts, and concerns over potential sales shortfalls. Analyst Commentary Analysts see Essity trading at a trough valuation as it shifts focus away from tissue towards higher-margin segments, but lack near-term catalysts for upward share price movement.
Nieuw narratief • Nov 07
Consumer Goods Innovation And Emerging Market Expansion Propel Thriving Growth
Growth in high-margin categories aims to improve net margins and profitability through stronger product mix and pricing strategies.Rendement voor aandeelhouders
| ESSITY B | SE Household Products | SE Markt | |
|---|---|---|---|
| 7D | 0.1% | -0.3% | -0.3% |
| 1Y | 7.6% | -6.9% | 11.3% |
Rendement versus industrie: ESSITY B overtrof de Swedish Household Products industrie, die het afgelopen jaar een rendement -6.9 % opleverde.
Rendement versus markt: ESSITY B presteerde slechter dan Swedish Market, dat het afgelopen jaar een rendement van 11.3 % opleverde.
Prijsvolatiliteit
| ESSITY B volatility | |
|---|---|
| ESSITY B Average Weekly Movement | 2.9% |
| Household Products Industry Average Movement | 3.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in SE Market | 10.4% |
| 10% least volatile stocks in SE Market | 2.9% |
Stabiele aandelenkoers: ESSITY B heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de Swedish markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van ESSITY B is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1849 | 36,000 | Ulrika Kolsrud | www.essity.com |
Essity AB (publ) ontwikkelt, produceert en verkoopt hygiëne- en gezondheidsproducten en -diensten in Europa, Noord- en Latijns-Amerika, Azië en internationaal. Het bedrijf is actief in drie segmenten: Gezondheid & Medisch, Consumentengoederen en Professionele Hygiëne. Het segment Gezondheid & Medisch biedt incontinentieproducten, wondverzorging, compressietherapie, orthopedie, huidverzorgingsproducten, vochtige doekjes, washandjes en digitale oplossingen met sensortechnologie onder de merknamen TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner en Hydrofera aan gezinsverzorgers, professionele zorgverleners en patiënten en consumenten via apotheken, winkels voor medische hulpmiddelen, ziekenhuizen, distributeurs, zorginstellingen en e-commerce.
Essity AB (publ) Samenvatting
| ESSITY B fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | SEK 177.29b |
| Inkomsten(TTM) | SEK 12.12b |
| Inkomsten(TTM) | SEK 137.57b |
14.6x
Koers/Winstverhouding1.3x
P/S-verhoudingIs ESSITY B overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ESSITY B resultatenrekening (TTM) | |
|---|---|
| Inkomsten | SEK 137.57b |
| Kosten van inkomsten | SEK 91.77b |
| Brutowinst | SEK 45.80b |
| Overige uitgaven | SEK 33.68b |
| Inkomsten | SEK 12.12b |
Laatst gerapporteerde inkomsten
Jun 30, 2026
Volgende inkomensdatum
Oct 22, 2026
| Winst per aandeel (EPS) | 17.88 |
| Brutomarge | 33.29% |
| Nettowinstmarge | 8.81% |
| Schuld/Eigen Vermogen Verhouding | 45.7% |
Hoe presteerde ESSITY B op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
3.3%
Huidig dividendrendement49%
UitbetalingsratioBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/18 18:06 |
| Aandelenkoers aan het einde van de dag | 2026/09/18 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Essity AB (publ) wordt gevolgd door 25 analisten. 14 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| null null | ABG Sundal Collier |
| Warren Ackerman | Barclays |
| Iain Simpson | Barclays |